BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toomey D, Smyth G, Condron C, Kelly J, Byrne AM, Kay E, Conroy RM, Broe P, Bouchier-Hayes D. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. Int J Cancer 2003;103:408-12. [PMID: 12471625 DOI: 10.1002/ijc.10836] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Shanmugam G, Das S, Paul S, Rakshit S, Sarkar K. Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer. Med Oncol 2022;39:237. [PMID: 36175603 DOI: 10.1007/s12032-022-01841-6] [Reference Citation Analysis]
2 Frafjord A, Skarshaug R, Hammarström C, Stankovic B, Dorg LT, Aamodt H, Woldbaek PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A. Antibody combinations for optimized staining of macrophages in human lung tumours. Scand J Immunol 2020;92:e12889. [PMID: 32299134 DOI: 10.1111/sji.12889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Cao L, Che X, Qiu X, Li Z, Yang B, Wang S, Hou K, Fan Y, Qu X, Liu Y. M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer. Cancer Manag Res 2019;11:6125-38. [PMID: 31308749 DOI: 10.2147/CMAR.S199832] [Cited by in Crossref: 30] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
4 Cullis J, Das S, Bar-Sagi D. Kras and Tumor Immunity: Friend or Foe? Cold Spring Harb Perspect Med. 2018;8. [PMID: 29229670 DOI: 10.1101/cshperspect.a031849] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
5 Deng Y, Yang Y, Yao B, Ma L, Wu Q, Yang Z, Zhang L, Liu B. RETRACTED: Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages. Experimental Cell Research 2018;364:208-16. [DOI: 10.1016/j.yexcr.2018.02.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
6 Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Vaitkiene S, Sakalauskas R. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol 2018;19:3. [PMID: 29361917 DOI: 10.1186/s12865-018-0241-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 103] [Article Influence: 21.5] [Reference Citation Analysis]
7 Conway EM, Pikor LA, Kung SH, Hamilton MJ, Lam S, Lam WL, Bennewith KL. Macrophages, Inflammation, and Lung Cancer. Am J Respir Crit Care Med. 2016;193:116-130. [PMID: 26583808 DOI: 10.1164/rccm.201508-1545ci] [Cited by in Crossref: 95] [Cited by in F6Publishing: 132] [Article Influence: 15.8] [Reference Citation Analysis]
8 Lin MW, Yang CY, Kuo SW, Wu CT, Chang YL, Yang PC. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas. Ann Surg Oncol 2016;23:3071-81. [PMID: 27150441 DOI: 10.1245/s10434-016-5244-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
9 Almatroodi SA, McDonald CF, Darby IA, Pouniotis DS. Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC. Cancer Microenviron 2016;9:1-11. [PMID: 26319408 DOI: 10.1007/s12307-015-0174-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 78] [Article Influence: 9.4] [Reference Citation Analysis]
10 Lahmar Q, Keirsse J, Laoui D, Movahedi K, Van Overmeire E, Van Ginderachter JA. Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment. Biochim Biophys Acta 2016;1865:23-34. [PMID: 26145884 DOI: 10.1016/j.bbcan.2015.06.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
11 Li Y, Sun BS, Pei B, Li CG, Zhang ZF, Yin YS, Wang CL. Osteopontin-expressing macrophages in non-small cell lung cancer predict survival. Ann Thorac Surg 2015;99:1140-8. [PMID: 25725928 DOI: 10.1016/j.athoracsur.2014.11.054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
12 Fantini MC, Becker C, Neurath MF. Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy. Expert Review of Anticancer Therapy 2014;5:681-94. [DOI: 10.1586/14737140.5.4.681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Prado-Garcia H, Romero-Garcia S, Lopez-Gonzalez JS. Activated T cells, but not lung tumor cells, express fas ligand. Ann Thorac Surg 2014;97:379-80. [PMID: 24384206 DOI: 10.1016/j.athoracsur.2013.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Li X, Tai HH. Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells. PLoS One 2013;8:e54073. [PMID: 23349788 DOI: 10.1371/journal.pone.0054073] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
15 Prado-Garcia H, Romero-Garcia S, Aguilar-Cazares D, Meneses-Flores M, Lopez-Gonzalez JS. Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin Dev Immunol 2012;2012:741741. [PMID: 23118782 DOI: 10.1155/2012/741741] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
16 Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer. 2011;105:93-103. [PMID: 21629244 DOI: 10.1038/bjc.2011.189] [Cited by in Crossref: 675] [Cited by in F6Publishing: 731] [Article Influence: 61.4] [Reference Citation Analysis]
17 O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ. The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 2010;5:2024-36. [PMID: 21155185 DOI: 10.1097/jto.0b013e3181f387e4] [Cited by in Crossref: 153] [Cited by in F6Publishing: 166] [Article Influence: 13.9] [Reference Citation Analysis]
18 St Hill CA, Krieser K, Farooqui M. Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior. Cancer 2011;117:4493-505. [PMID: 21437888 DOI: 10.1002/cncr.26059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
19 Kang JC, Chen JS, Lee CH, Chang JJ, Shieh YS. Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J Surg Oncol. 2010;102:242-248. [PMID: 20740582 DOI: 10.1002/jso.21617] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 7.2] [Reference Citation Analysis]
20 Dai F, Liu L, Che G, Yu N, Pu Q, Zhang S, Ma J, Ma L, You Z. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer. BMC Cancer 2010;10:220. [PMID: 20487543 DOI: 10.1186/1471-2407-10-220] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 7.8] [Reference Citation Analysis]
21 Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010;10:112. [PMID: 20338029 DOI: 10.1186/1471-2407-10-112] [Cited by in Crossref: 253] [Cited by in F6Publishing: 278] [Article Influence: 21.1] [Reference Citation Analysis]
22 Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, Lee SH, Im SA, Chung DH, Kim YT, Kim TY, Bang YJ, Sung SW, Kim JH, Heo DS. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 2008;98:1118-24. [PMID: 18283317 DOI: 10.1038/sj.bjc.6604256] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
23 Prado-garcia H, Aguilar-cazares D, Meneses-flores M, Morales-fuentes J, Lopez-gonzalez JS. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunol Immunother 2008;57:325-36. [DOI: 10.1007/s00262-007-0372-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schoenhals JE, Seyedin SN, Anderson C, Brooks ED, Li YR, Younes AI, Niknam S, Li A, Barsoumian HB, Cortez MA, Welsh JW. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation. Transl Lung Cancer Res 2017;6:148-58. [PMID: 28529897 DOI: 10.21037/tlcr.2017.03.06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
25 Verdegaal EM, Hoogstraten C, Sandel MH, Kuppen PJ, Brink AA, Claas FH, Gorsira MC, Graadt van Roggen JF, Osanto S. Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma. Cancer Immunol Immunother 2007;56:587-600. [PMID: 16924494 DOI: 10.1007/s00262-006-0214-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
26 Welsh TJ, Green RH, Richardson D, Waller DA, O’Byrne KJ, Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol. 2005;23:8959-8967. [PMID: 16219934 DOI: 10.1200/jco.2005.01.4910] [Cited by in Crossref: 240] [Cited by in F6Publishing: 235] [Article Influence: 14.1] [Reference Citation Analysis]
27 Ichim CV. Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy. J Transl Med 2005;3:8. [PMID: 15698481 DOI: 10.1186/1479-5876-3-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
28 Trojan A, Urosevic M, Dummer R, Giger R, Weder W, Stahel RA. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer. Lung Cancer 2004;44:143-7. [PMID: 15084378 DOI: 10.1016/j.lungcan.2003.11.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]